Item 16. Form 10-K Summary

6K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

The optional summary in Item 16 has not been included in this Form 10-K.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


			MASCO CORPORATION
			By:			/s/ John G. Sznewajs
						John G. Sznewajs Vice President, Chief Financial Officer

February 9, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.


Principal Executive Officer:
/s/ Keith J. Allman	President and Chief Executive Officer and Director
Keith J. Allman
Principal Financial Officer:
/s/ John G. Sznewajs	Vice President, Chief Financial Officer
John G. Sznewajs
Principal Accounting Officer:
/s/ John P. Lindow	Vice President, Controller and Chief Accounting Officer
John P. Lindow
/s/ J. Michael Losh	Chairman of the Board
J. Michael Losh
/s/ Richard A. Manoogian	Chairman Emeritus
Richard A. Manoogian
/s/ Mark R. Alexander	Director
Mark R. Alexander		February 9, 2021
/s/ Marie A. Ffolkes	Director
Marie A. Ffolkes
/s/ Christopher A. O'Herlihy	Director
Christopher A. O'Herlihy
/s/ Donald R. Parfet	Director
Donald R. Parfet
/s/ Lisa A. Payne	Director
Lisa A. Payne
/s/ John C. Plant	Director
John C. Plant
/s/ Charles K. Stevens, III
Charles K. Stevens, III	Director
/s/ Reginald M. Turner, Jr.	Director
Reginald M. Turner, Jr.

MASCO CORPORATION

SCHEDULE II. VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended December 31, 2020, 2019 and 2018


	(In Millions)
Column A	Column B			Column C					Column D			Column E
				Additions
Description	Balance at Beginning of Period			Charged to Costs and Expenses		Charged to Other Accounts			Deductions			Balance at End of Period
Allowances for doubtful accounts, deducted from accounts receivable in the balance sheet:
2020	$	5	(a)	$	3	$	—		$	(1)	(b)	$	7
2019	$	5		$	1	$	—		$	(2)	(b)	$	4
2018	$	4		$	3	$	—		$	(2)	(b)	$	5
Valuation allowance on deferred tax assets:
2020	$	38		$	—	$	2	(c)	$	(5)	(d)	$	35
2019	$	43		$	—	$	—		$	(5)	(d)	$	38
2018	$	47		$	—	$	—		$	(4)	(e)	$	43

______________________________

**(a)**Includes a $1 million adjustment related to the cumulative effect of adoption of the new credit loss standard (refer to Note A).

**(b)**Deductions, representing uncollectible accounts written off, less recoveries of accounts written off in prior years.

(c)$2 million net increase in valuation allowance due to currency translation recorded in other comprehensive income (loss).

(d)$5 million net reduction to valuation allowance recorded as an income tax benefit.

(e)$3 million net reduction to valuation allowance recorded as an income tax benefit and $1 million reduction recorded primarily in other comprehensive income (loss).

Previous: Item 15. Exhibits and Financial Statement Schedules.